Electronic cigarettes

Electronic cigarettes has been studied in 37 papers since 2021: 1 trial and 16 observational studies in people, 19 reviews; 28 in the past year. The newest paper, Oct 16, 2026: “The effects of electronic nicotine delivery systems on metabolic markers - a systematic review”.

Exposure

37 papers study it30 findingsUpdated

See all 36 papers on electronic cigarettes

At a glance

Human studies link electronic cigarettes with oxidative stress and respiratory disease; independent labs report the oxidative-stress association. Reviews describe smoking-cessation benefits but disagree on hypertension, with a review showing no clear effect for exclusive use. Authors include company employees, and papers declare company ties.

30 findings in 19 papers from 2021 to 2026, 5 of them since June 2026

Independent labs found the same change in people. 13 independent labs in 10 countries.

“At 8 weeks, 7-day PPA did not differ significantly between e-cigarette and NRT groups [25 (14.3%) of 175 and 17 (9.7%) of 175, respectively; OR 1.56; 95% CI 0.80-3.04; p = 0.19].”
E-cigarettes versus combination nicotine replacement therapy following a recent failed quit attempt: a pragmatic randomized trial through state tobacco quitlinesLancet regional health. Americas2026doi:10.1016/j.lana.2025.101351

2 of its findings point the other way.

Humans: replicated by independent labs. Cells, worms or flies and mice: nothing yet.
  • 13 independent labs in 10 countries
  • 2 findings against
  • Funders: National Institute for Health Research and others
  • 5 of 24 findings with company ties
  • Human trial1
  • Humans16
  • In silico1

What did studies of electronic cigarettes find?

16

Studies of electronic cigarettes measured 16 outcomes; the most studied is smoking cessation (3 studies).

Smoking cessation

upin humans3OR 1.17–1.67

3 studies
  1. Electronic cigarettes are linked with better smoking cessation in humans (smoking cessation attempt) (ORadj = 1.50 [0.96-2.34]).

    “E-cigarettes appeared to be effective for helping older adults to stop smoking (ORadj = 1.50 [0.96-2.34])”

    Humanssmoking cessation attempt

    Use, perceptions, and effectiveness of e-cigarettes for smoking cessation among older adults in England: a population study, 2014-2024

    BMC medicine

  2. Electronic cigarettes improve smoking cessation in humans (compared with FDA-approved nicotine replacement therapies).

    “E-cigarettes with nicotine are less harmful than cigarettes and have been shown to be more effective for smoking cessation than US Food and Drug Administration-approved nicotine replacement therapies.”

    Reviewcompared with FDA-approved nicotine replacement therapieswith nicotine

    Nicotine E-Cigarettes for Cigarette Smoking Cessation: Recommendations to US-Based Clinicians

    JAMA

  3. Electronic cigarettes increase smoking cessation in humans (versus other interventions) (RR/OR 1.17-1.67 vs NRT, 1.46-2.09 vs non-nicotine EC).

    “all reported point estimates favouring nicotine EC for smoking cessation”

    Reviewversus other interventions

    Electronic cigarettes for smoking cessation: An overview of systematic reviews and evidence and gap map

    Addiction (Abingdon, England)

Augmentation index

upin humans1

1 study
  1. Electronic cigarettes increase augmentation index in humans (nicotine-containing products exposure) (SMD=1.05 [95% CI: 0.34-1.76, p=0.008]).

    “The AIx analysis included 9 studies (n=190) and also demonstrated a significant increase (SMD=1.05 [95% CI: 0.34-1.76, p=0.008]).”

    Reviewnicotine-containing products exposuren = 190

    Acute Effects of Electronic Cigarettes and Heated Tobacco Products on Vascular Stiffness: A Systematic Review and Meta-Analysis

    Current cardiology reviews

More on Augmentation index

Pulse wave velocity

upin humans1

1 study
  1. Electronic cigarettes increase pulse wave velocity in humans (nicotine-containing products exposure) (SMD=1.71 [95% CI: 0.23-3.19, p=0.031]).

    “The PWV analysis included 6 studies (n=133) and demonstrated a significant increase following exposure to nicotine-containing products (SMD=1.71 [95% CI: 0.23-3.19, p=0.031]).”

    Reviewnicotine-containing products exposuren = 133

    Acute Effects of Electronic Cigarettes and Heated Tobacco Products on Vascular Stiffness: A Systematic Review and Meta-Analysis

    Current cardiology reviews

More on Pulse wave velocity

Hypertension

no changein humans1OR 1.09

1 study
  1. Electronic cigarettes showed no clear effect on hypertension in humans (exclusive e-cigarette use) (OR 1.09, 95% CI 0.88-1.36).

    “the pooled estimate for exclusive e-cigarette use included the null (OR 1.09, 95% CI 0.88-1.36; I2 = 68.1%)”

    Reviewexclusive e-cigarette use

    Associations of exclusive e-cigarette use and dual use of e-cigarettes and combustible cigarettes with prevalent and incident hypertension: A systematic review and meta-analysis

    American journal of preventive cardiology

More on Hypertension

Adverse events

no changein humans1

1 study
  1. Electronic cigarettes showed no clear effect on adverse events in humans (nicotine EC vs other interventions).

    “For adverse events, pooled estimates generally indicated little or no difference between groups.”

    Reviewnicotine EC vs other interventions

    Electronic cigarettes for smoking cessation: An overview of systematic reviews and evidence and gap map

    Addiction (Abingdon, England)

Stroke

upin reviews1

1 study
  1. Electronic cigarettes increase stroke under ischemic conditions.

    “impaired cerebral glucose transport, particularly under ischemic conditions, resulting in exacerbated stroke severity”

    Reviewunder ischemic conditions

    Uncovering the neurophysiological parallels between vaping and traditional cigarette smoking

    Discover Neuroscience

More on Stroke

Blood-brain barrier permeability

upin reviews1

1 study
  1. Electronic cigarettes increase blood-brain barrier permeability.

    “e-cigarette exposure consistently downregulated BBB tight junction proteins (ZO-1, claudin-3) and increased permeability, oxidative stress, and inflammatory markers”

    Review

    Uncovering the neurophysiological parallels between vaping and traditional cigarette smoking

    Discover Neuroscience

Oxidative stress and ROS signaling

upin humans1

1 study
  1. Electronic cigarettes are linked with oxidative stress and ROS signaling in humans.

    “Elevated IFN-γ and MDA levels indicated increased inflammation and oxidative stress in vapers.”

    Humans

    Impact of E-Cigarette Use on Circadian Proteins and Cardiovascular Risk Markers

    Journal of cardiovascular translational research

More on Oxidative stress and ROS signaling

Inflammation

upin humans1

1 study
  1. Electronic cigarettes are linked with inflammation in humans.

    “Elevated IFN-γ and MDA levels indicated increased inflammation and oxidative stress in vapers.”

    Humans

    Impact of E-Cigarette Use on Circadian Proteins and Cardiovascular Risk Markers

    Journal of cardiovascular translational research

More on Inflammation

Circadian clock

downin humans1

1 study
  1. Electronic cigarettes are linked with circadian clock in humans.

    “Vaping significantly decreased Melatonin, PER1, PER2, CRY1, and CRY2, while BMAL1 remained unchanged.”

    Humans

    Impact of E-Cigarette Use on Circadian Proteins and Cardiovascular Risk Markers

    Journal of cardiovascular translational research

More on Circadian clock

Smoking behavior

downin humans1

1 study
  1. Electronic cigarettes decrease smoking behavior in humans (recent failed quit attempt).

    “Both groups showed similar reductions in cigarette use and dependence.”

    Human trialrecent failed quit attempt8 weeksn = 350

    E-cigarettes versus combination nicotine replacement therapy following a recent failed quit attempt: a pragmatic randomized trial through state tobacco quitlines

    Lancet regional health. Americas

Smoking abstinence

no changein humans1OR 1.56

1 study
  1. Electronic cigarettes showed no clear effect on smoking abstinence in humans (recent failed quit attempt) (14.3% vs 9.7%; OR 1.56, 95% CI 0.80-3.04, p = 0.19).

    “At 8 weeks, 7-day PPA did not differ significantly between e-cigarette and NRT groups [25 (14.3%) of 175 and 17 (9.7%) of 175, respectively; OR 1.56; 95% CI 0.80-3.04; p = 0.19].”

    Human trialrecent failed quit attemptJUUL e-cigarettes vs nicotine patch and lozenge8 weeksn = 350

    E-cigarettes versus combination nicotine replacement therapy following a recent failed quit attempt: a pragmatic randomized trial through state tobacco quitlines

    Lancet regional health. Americas

All 16

What is electronic cigarettes linked with?

12

Studies link electronic cigarettes with 12 measures, among them asthma, smoking prevalence and coronary artery disease.

Asthma

upin humans1

1 study
  1. Electronic cigarettes raise the risk of asthma in humans (epidemiologic and experimental studies).

    “A growing body of experimental and epidemiologic evidence has implicated e-cigarette use in the pathogenesis of respiratory diseases such as chronic obstructive pulmonary disease, lung cancer, interstitial lung disease, and asthma.”

    Reviewepidemiologic and experimental studies

    Use of electronic cigarettes and asthma across the lifespan

    The Journal of allergy and clinical immunology

More on Asthma

Smoking prevalence

downin humans1

1 study
  1. Electronic cigarettes are associated with smoking prevalence in humans following regulatory clarification and endorsement as a cessation aid (below 7%).

    “from 2018/19, smoking prevalence declined rapidly, coinciding with increased uptake of vaping following regulatory clarification and their endorsement as a cessation aid.”

    Reviewfollowing regulatory clarification and endorsement as a cessation aid

    New Zealand's accelerating smoking decline: lessons for tobacco harm reduction

    The Lancet regional health. Western Pacific

Coronary artery disease

upin humans1OR 1.19

1 study
  1. Electronic cigarettes raise the risk of coronary artery disease in humans (OR = 1.19, p < 0.0001).

    “significantly higher pooled odds of coronary heart disease (OR = 1.19, p < 0.0001)”

    Review

    Electronic cigarettes and cardiovascular outcomes: a systematic review and meta-analysis of Major Adverse Cardiovascular Events (MACE)

    BMC public health

More on Coronary artery disease

Stroke

upin humans1OR 1.62

1 study
  1. Electronic cigarettes raise the risk of stroke in humans (OR = 1.62, p < 0.01).

    “stroke (OR = 1.62, p < 0.01)”

    Review

    Electronic cigarettes and cardiovascular outcomes: a systematic review and meta-analysis of Major Adverse Cardiovascular Events (MACE)

    BMC public health

More on Stroke

Major adverse cardiovascular events

upin humans1OR 1.57

1 study
  1. Electronic cigarettes raise the risk of major adverse cardiovascular events in humans (OR = 1.57, p < 0.0001).

    “major adverse cardiovascular events (MACE) (OR = 1.57, p < 0.0001)”

    Review

    Electronic cigarettes and cardiovascular outcomes: a systematic review and meta-analysis of Major Adverse Cardiovascular Events (MACE)

    BMC public health

Hypertension

upin humans1

1 study
  1. Electronic cigarettes raise the risk of hypertension in humans.

    “current evidence suggests significant adverse cardiovascular effects, including an increased risk of hypertension.”

    Review

    Impact of electronic cigarette use on blood pressure: A systematic review

    Heart & lung : the journal of critical care

More on Hypertension

Age-related macular degeneration

no changein humans1OR 1.08

1 study
  1. Electronic cigarettes are associated with age-related macular degeneration in humans (OR 1.08 (95% CI, 0.73 to 1.60)).

    “1.08 (95% CI, 0.73 to 1.60) in adults who used e-cigarettes, compared to those who had never used these products.”

    Humansn = 26,689

    Associations between Electronic Cigarettes, Smokeless Tobacco, and Age-related Macular Degeneration in the 2017 United States National Health Interview Survey

    Journal of vitreoretinal diseases

More on Age-related macular degeneration

Oxidative stress and ROS signaling

upin humans1

1 study
  1. Electronic cigarettes are associated with oxidative stress and ROS signaling in humans (former smokers).

    “EC smoking was related to higher vascular stiffness and oxidative stress, although to a lesser degree compared to conventional cigarette smoking.”

    Reviewformer smokers

    Impact of E-cigarette Use on Cardiovascular Risk Markers in Elderly Former Smokers: A Systematic Review and Meta-Analysis

    Cureus

More on Oxidative stress and ROS signaling

Arterial stiffness

upin humans1

1 study
  1. Electronic cigarettes are associated with arterial stiffness in humans (former smokers).

    “The overall analysis demonstrated that EC smoking was related to higher vascular stiffness and oxidative stress, although to a lesser degree compared to conventional cigarette smoking.”

    Reviewformer smokers

    Impact of E-cigarette Use on Cardiovascular Risk Markers in Elderly Former Smokers: A Systematic Review and Meta-Analysis

    Cureus

Cardiovascular risk

upin humans1

1 study
  1. Electronic cigarettes are associated with cardiovascular risk in humans (former smokers) (r = 0.60, 95% CI: 0.45-0.81).

    “The total effect size indicated a positive but moderate relationship (r = 0.60, 95% CI: 0.45-0.81) between EC smoking and cardiovascular risks.”

    Reviewformer smokers

    Impact of E-cigarette Use on Cardiovascular Risk Markers in Elderly Former Smokers: A Systematic Review and Meta-Analysis

    Cureus

All 12

Funding

4 grants since 2018

National Cancer Institute$3.3MNational Institute on Drug Abuse$2.3MNational Institute for Health Research£390K

Contains public sector information licensed under the Open Government Licence v3.0.

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Human reviews describe increased augmentation index and pulse wave velocity with nicotine-containing electronic cigarettes, no hypertension effect with exclusive use, and smoking prevalence below 7% following regulatory clarification and cessation-aid endorsement. Work spans two independent labs in two countries; GlaxoSmithKline funds one finding, and a paper declares an interest of the product's maker.

  2. Summary written from the findings.

Latest

Dec 2025: 3Jan 2026: 5Feb 2026: 3Mar 2026: 5Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 5Aug 2026: 1Sep 2026: 2Oct 2026: 1Nov 2026: 026 papers in 12 months

See all 36 papers on electronic cigarettes